Stockholm - Delayed Quote SEK
Neola Medical AB (publ) (NEOLA.ST)
At close: October 25 at 12:35 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
--
--
--
625.0000
31.0000
--
Cost of Revenue
-9,033.0000
-8,019.0000
-8,017.0000
-8,427.0000
-1,506.0000
--
Gross Profit
9,033.0000
8,019.0000
8,017.0000
9,052.0000
1,537.0000
--
Operating Expense
19,298.0000
17,645.0000
18,402.0000
15,705.0000
8,253.0000
--
Operating Income
-10,265.0000
-9,626.0000
-10,385.0000
-6,653.0000
-6,716.0000
--
Net Non Operating Interest Income Expense
788.0000
612.0000
33.0000
--
-1.0000
--
Pretax Income
-9,471.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
--
Net Income Common Stockholders
-9,471.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
--
Diluted NI Available to Com Stockholders
-9,471.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
--
Basic EPS
-0.16
-0.17
-0.40
-0.47
-0.71
--
Diluted EPS
-0.16
-0.17
-0.40
-0.47
-0.71
--
Basic Average Shares
62,997.5230
55,765.5580
26,070.5860
14,013.8570
9,522.2720
--
Diluted Average Shares
70,150.2340
55,765.5580
26,070.5860
14,013.8570
9,522.2720
--
Total Operating Income as Reported
-10,259.0000
-9,621.0000
-10,386.0000
-6,653.0000
-6,716.0000
--
Total Expenses
10,265.0000
9,626.0000
10,385.0000
7,278.0000
6,747.0000
--
Net Income from Continuing & Discontinued Operation
-9,471.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
--
Normalized Income
-9,471.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
--
Interest Expense
--
--
--
--
1.0000
--
Net Interest Income
788.0000
612.0000
33.0000
--
-1.0000
--
EBIT
-10,265.0000
-9,626.0000
-10,385.0000
-6,653.0000
-6,716.0000
--
EBITDA
-8,666.0000
-8,033.0000
-9,348.0000
-6,638.0000
-6,709.0000
--
Reconciled Cost of Revenue
-9,033.0000
-8,019.0000
-8,017.0000
-8,427.0000
-1,506.0000
--
Reconciled Depreciation
1,599.0000
1,593.0000
1,037.0000
15.0000
7.0000
--
Net Income from Continuing Operation Net Minority Interest
-9,471.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
--
Total Unusual Items Excluding Goodwill
--
--
--
--
--
10.0000
Total Unusual Items
--
--
--
--
--
10.0000
Normalized EBITDA
-8,666.0000
-8,033.0000
-9,348.0000
-6,638.0000
-6,709.0000
--
12/31/2019 - 10/2/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade